BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 0.9980
-0.0020 (-0.20%)
Nov 6, 2026, 3:27 PM CET
BioPorto Market Cap
BioPorto has a market cap or net worth of 494.12 million as of November 6, 2026. It is the 27,023rd most valuable company in the world and the 82nd biggest in Denmark. Its market cap has decreased by 2.96% in one year.
Market Cap
494.12M
Enterprise Value
425.51M
Revenue
38.37M
Global Rank
Country Rank
#82 Denmark
PE Ratio
n/a
ChartMarket Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 494.12M, an increase of 556.39%. That is a compound annual growth rate of 9.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 494.12M | -2.15% |
| Dec 30, 2025 | 505.00M | -24.17% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.19T |
| Genmab | 222.23B |
| Coloplast | 111.62B |
| Demant | 77.15B |
| Gubra | 4.93B |
| Pharma Equity Group | 86.91M |
| Scandinavian Medical Solutions | 77.02M |
| ViroGates | 62.65M |